This is a preview of subscription content, log in via an institution to check access.
Reference
Decision Resources. The Ulcerative Colitis Drug Market Will Increase From $2.1 Billion in 2012 to $3.6 Billion in 2022. Media Release : 9 Oct 2013. Available from: URL: http://www.decisionresourcesgroup.com
Rights and permissions
About this article
Cite this article
Drugs sales for ulcerative colitis set to rise to $US3.6 billion by 2022. PharmacoEcon Outcomes News 689, 11 (2013). https://doi.org/10.1007/s40274-013-0809-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0809-4